Pharmacology, Toxicology and Pharmaceutical Science
Acinetobacter Baumannii
15%
Adrenal Cortex Carcinoma
11%
Adverse Event
20%
Antibiotics
54%
Antiinfective Agent
61%
Aortic Aneurysm
11%
Asymptomatic Bacteriuria
11%
Atypical Mycobacterium
11%
Bacterial Endocarditis
11%
Bladder Cancer
13%
Bloodstream Infection
99%
Carbapenem
19%
Case-Control Study
14%
Cefazolin
11%
Cohort Study
35%
Cross-Sectional Study
11%
Disease
12%
Enterobacteriaceae
11%
Extended Spectrum Beta Lactamase Producing Escherichia Coli
11%
Febrile Neutropenia
17%
Gram Negative Bacterium
11%
Gram Positive Cocci
12%
Infection
69%
Intervertebral Disk Degeneration
11%
Klebsiella
11%
Linezolid
11%
Liver Cirrhosis
12%
Malignant Neoplasm
11%
Measles
11%
Methicillin Resistant Staphylococcus Aureus Infection
54%
Methicillin Susceptible Staphylococcus Aureus
21%
Methicillin-Resistant Staphylococcus Aureus
16%
Meticillin
34%
Microorganism
13%
Minimum Inhibitory Concentration
12%
Mycobacterium bovis
11%
Nafcillin
11%
Pneumococcal Infection
11%
Prospective Cohort Study
11%
Pseudomonas aeruginosa
21%
Receptor
11%
Retrospective Study
11%
Spondylitis
47%
Staphylococcal Bacteremia
47%
Staphylococcal Infection
23%
Staphylococcus Aureus
58%
Streptococcus
14%
Sunitinib
11%
Tuberculous Spondylitis
11%
Vancomycin
32%
Medicine and Dentistry
Acinetobacter Baumannii
15%
Adrenal Cortex Carcinoma
11%
Antibiogram
17%
Antibiotic Therapy
21%
Antibiotics
30%
Antiinfective Agent
64%
Aortic Aneurysm
11%
Atypical Mycobacterium
11%
Awareness
21%
Bladder Cancer
13%
Blood Culture
17%
Bloodstream Infection
77%
Carbapenem
13%
Case-Control Study
13%
Consultation
11%
Disease
11%
Enterobacteriaceae
11%
Extended Spectrum Beta Lactamase Producing Escherichia Coli
11%
Febrile Neutropenia
29%
Gram-Negative Bacteria
15%
Hand Hygiene
23%
Infection
48%
Infective Endocarditis
13%
Intervertebral Disk Degeneration
11%
Invasive Aspergillosis
11%
Klebsiella
11%
Liver Cirrhosis
12%
Lung Tuberculosis
11%
Malignant Neoplasm
11%
Methicillin Resistant Staphylococcus Aureus
13%
Methicillin Resistant Staphylococcus Aureus Infection
17%
Middle East Respiratory Syndrome
11%
Middle East Respiratory Syndrome Coronavirus
11%
Mycobacterium bovis
11%
Needle Biopsy
11%
Odds Ratio
20%
Outpatient
14%
Patient Isolation
14%
Patient Participation
11%
Pneumococcus
11%
Prospective Cohort Study
11%
Pseudomonas aeruginosa
21%
Retrospective Study
14%
Serotype
11%
Spondylitis
68%
Staphylococcus Aureus
15%
Sulfhemoglobinemia
11%
Sunitinib
11%
Tertiary Care
13%
Tuberculous Spondylitis
11%
Immunology and Microbiology
Abscess
21%
Acinetobacter Baumannii
23%
Antibiotic Sensitivity
15%
Antimicrobial Resistance
11%
C-Reactive Protein
23%
Comorbidity
15%
COVID-19
14%
Cytokine
11%
down Regulation
11%
Endocarditis
12%
Erythrocyte Sedimentation Rate
9%
Escherichia coli
16%
Extended Spectrum Beta Lactamase Producing Escherichia Coli
11%
Gram-Negative Bacteria
27%
Hospital Mortality
7%
Immunogenicity
9%
Immunology
9%
Infectious Agent
11%
Inoculum
16%
Klebsiella
11%
Leukocyte Count
15%
Measles
11%
Measles Antibody
11%
Methicillin Resistance
16%
Methicillin Susceptible Staphylococcus Aureus
26%
Methicillin-Resistant Staphylococcus Aureus
60%
Microorganism
42%
Middle East Respiratory Syndrome
11%
Middle East Respiratory Syndrome Coronavirus
11%
Minimum Inhibitory Concentration
26%
Mortality Rate
30%
Mycobacterium bovis
11%
Neutralizing Antibody
8%
Neutrophil Count
17%
Neutrophil Granulocyte
29%
Nontuberculous mycobacteria
13%
Pneumococcus
11%
Pseudomonas aeruginosa
13%
Receptor Binding
11%
Seroconversion
7%
Seropositivity
13%
Serotype
11%
Soft Tissue
15%
Spike
9%
Sputum Culture
17%
Staphylococcus Aureus
100%
Thoracic Spine
13%
Tissue Culture
21%
TLR2
11%
Vertebral Column
10%